Ampicillin-Sulbactam Versus Third-Generation Cephalosporins in Aspiration Pneumonia: A Nationwide Retrospective Cohort Study Researchers analyzed data from nearly 549,000 patients hospitalized with aspiration pneumonia in Japan between 2010 and 2022, using the national inpatient DPC database. Patients treated with ampicillin–sulbactam experienced significantly lower in-hospital mortality—14.6% versus 16.4%—and a reduced incidence of Clostridioides difficile infection—2.0% versus 2.8%...
